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Abstract
In vascular endothelium, the major research focus has been on reactive oxygen species (ROS) derived from
Nox2. The role of Nox4 in endothelial signal transduction, ROS production, and cytoskeletal reorganization is
not well defined. In this study, we show that human pulmonary artery endothelial cells (HPAECs) and human
lung microvascular endothelial cells (HLMVECs) express higher levels of Nox4 and p22phox compared to Nox1,
Nox2, Nox3, or Nox5. Immunofluorescence microscopy and Western blot analysis revealed that Nox4 and
p22phox, but not Nox2 or p47phox, are localized in nuclei of HPAECs. Further, knockdown of Nox4 with siRNA
decreased Nox4 nuclear expression significantly. Exposure of HPAECs to hyperoxia (3–24 h) enhanced mRNA
and protein expression of Nox4, and Nox4 siRNA decreased hyperoxia-induced ROS production. Interestingly,
Nox4 or Nox2 knockdown with siRNA upregulated the mRNA and protein expression of the other, suggest-
ing activation of compensatory mechanisms. A similar upregulation of Nox4 mRNA was observed in Nox2 /
ko mice. Downregulation of Nox4, or pretreatment with N-acetylcysteine, attenuated hyperoxia-induced cell
migration and capillary tube formation, suggesting that ROS generated by Nox4 regulate endothelial cell motil-
ity. These results indicate that Nox4 and Nox2 play a physiological role in hyperoxia-induced ROS production
and migration of ECs. Antioxid. Redox Signal. 11, 747–764.
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Introduction
REACTIVE OXYGEN SPECIES (ROS) are conventionallyviewed as toxic byproducts of cellular metabolism. On
the other hand, organisms possess enzymatic systems that
generate ROS under physiological conditions (36). Among
the enzymatic systems that are well characterized is the su-
peroxide-producing NADPH oxidase in mammalian
phagocytes that play crucial roles in host defense against
microbial infection (2, 3). The catalytic core of the phago-
cytic NADPH oxidase is the membrane-integrated flavocy-
tochrome b558, comprising the two subunits p22phox and
Nox2 (gp91phox); the latter contains a complete electron-
transferring apparatus from NADPH to molecular oxygen
with binding sites for heme, FAD, and NADPH (5, 8, 34).
The phagocytic NADPH oxidase, dormant in resting cells,
becomes activated during phagocytosis to generate super-
oxide (O2.-). The activation requires the two specialized cy-
tosolic proteins, p47phox and p67phox, and the small GTPase
Rac2, all of which are translocated upon cell stimulation to
the membrane to interact with and activate the flavocy-
tochrome (23). Such a strict regulation of the phagocyte ox-
idase activity is critical, as uncontrolled production of high
concentrations of ROS is injurious not only to phagocytes
themselves but also to their surrounding tissues. This may
further amplify the inflammatory response and perpetuate
tissue damage.
Although Nox2 is a critical component of the phagocytic
NADPH oxidase, the role of Nox2 and Nox2-generated ROS
in vascular cells remains somewhat controversial and may
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depend on specific cell types within the vessel wall (6, 38).
For example, expression of Nox2 has been reported in arte-
riolar smooth muscle cells (SMC), but not in aortic SMC. In
human pulmonary artery smooth muscle cells (PASMCs),
human urotensin II-mediated activation of NADPH oxidase
was abrogated by p22phox or Nox4 antisense oligonu-
cleotides, and depletion of Nox4 or p22phox blocked
urotensin-II, but not S1P, mediated proliferation of PASMCs
(9). These data suggest potential involvement of Nox4 or
p22phox in mitogenesis. Further, in 3T3-L1 adipocytes, Nox4
but not Nox2, appears to be the major mediator of insulin-
induced ROS production associated with oxidative inhibi-
tion of PTP1B activity (25). A role for Nox4 and JNK signal-
ing has been implicated in 7-ketocholesterol-mediated
NADPH oxidase activation and overproduction of ROS in
human aortic smooth muscle cells (28).
ROS, including hydrogen peroxide (H2O2) and O2., func-
tion as signaling molecules in vascular endothelial and
smooth muscle cells (24). We have demonstrated that hy-
peroxia activated human lung endothelial cell NADPH oxi-
dase with enhanced production of ROS including O2.(27).
Further, a role for Src kinase (7) and cortactin (37) in hyper-
oxia-induced activation of p47phox was demonstrated in hu-
man pulmonary artery endothelial cells (HPAECs). Recent
studies have shown that all the Nox and phox components
of phagocytic oxidase are also present in vascular cells (6);
however, the effect of hyperoxia on the expression of Nox
and phox proteins and their role in hyperoxia-induced
ROS/O2. are yet to be fully defined. In the present study,
we evaluated the expression profiles of Nox and phox fam-
ily of proteins under normoxia and hyperoxia and the role
of Nox4 and Nox2 in hyperoxia-induced ROS production.
Our results demonstrate that: (a) mRNA expressions of Nox4
and p22phox , as determined by real-time PCR, are very high
compared to other Nox and phox proteins; (b) exposure of
HPAECs to hyperoxia further enhanced the mRNA expres-
sions of Nox1, Nox2, Nox4, and p22phox;; (c) the protein ex-
pression of Nox2, Nox4, and p22phox, were also increased by
hyperoxia; (d) under normoxia, Nox4 in pulmonary artery
endothelial cells is predominantly expressed in the nucleus
as compared to Nox2 and p22phox, which are localized in the
cytoplasmic compartment; (e) Nox2 and Nox4 knockdown
with specific siRNAs attenuated hyperoxia-induced ROS
generation; (f) Nox4 siRNA upregulated mRNA and protein
expression of Nox2, while Nox2 siRNA increased the ex-
pression of Nox4; (g) deletion of Nox2 gene in mice upreg-
ulated expression of Nox4 and Nox2/ mice exhibited ROS
accumulation in bronchoalveolar lavage (BAL) fluids; and
(h) exposure of Nox2/ mice to hyperoxia did not further
increase Nox4 mRNA levels.
Materials and Methods
Materials
HPAECs, human lung microvascular endothelial cells
(HLMVECs), EBM-2 basal media, and Bullet kit were ob-
tained from Clonetics (San Diego, CA). Phosphate-buffered
saline (PBS) was from Biofluids Inc. (Rockville, MD). Ampi-
cillin, fetal bovine serum (FBS), trypsin, MgCl2, EGTA, Tris-
HCl, Triton X-100, sodium orthovanadate, aprotinin, Tween
20, ferricytochrome c, polyethylene glycol-(PEG) conjugated
superoxide dismutase (SOD), and H2O2 (30%), were all ob-
tained from Sigma (St. Louis, MO). Dihydroethidium (hy-
droethidine), 6-carboxy-2,7-dichlorodihydrofluorescein di-
acetate, di (acetoxymethyl ester) (DCFDA), were purchased
from Molecular Probes (Eugene, OR). ECL kit was from
Amersham Biosciences, Piscataway, NJ. SMART Pool® small
interfering RNA duplex oligonucleotides targeting p47phox
were purchased from Dharmacon, Inc. (Lafayette, CO). Nox4
siRNA was purchased from Ambion (Austin, TX), and Nox2
siRNA were purchased from Santa Cruz Biotechnology
(Santa Cruz, CA). Polyclonal antibodies to Nox4, Nox2, and
p22phox were procured from Santa Cruz Biotechnology. Cal-
reticulin was purchased from Abcam. (Cambridge, MA).
Nox4 antibody for Immunocytochemistry was provided by
Dr. David Lambeth (Emory University, Atlanta, GA).
Endothelial cell culture
HPAECs and HLMVECs, passages between 5 and 8, were
grown in EGM-2 complete media with 10% FBS, 100
Units/ml penicillin, and streptomycin in a 37°C incubator
under 5% CO2, 95% air atmosphere, and grown to contact-
inhibited monolayers with typical cobblestone morphology
as described previously (7, 27). Cells from T-75 flasks were
detached with 0.05% trypsin, resuspended in fresh complete
medium, and cultured in 35- or 60-mm dishes or on glass
coverslips for immunofluorescence studies.
Exposure of cells to hyperoxia
HPAECs (90% confluence) in complete EGM-2 medium
were placed in a humidity-controlled airtight modulator in-
cubator chamber (Billups-Rothenberg, Del Mar, CA), flushed
continuously with 95% O2, 5% CO2 for 30 min until the oxy-
gen level inside the chamber reached 95%. HPAECs were
then placed in a cell culture incubator at 37°C for the desired
lengths of time (3–72 h). The concentration of O2 inside the
chamber was monitored with a digital oxygen monitor. The
buffering capacity of the cell culture medium did not change
significantly during the period of hyperoxic exposure and
was maintained at a pH 7.4. In some experiments, cells
were pretreated with PEG-conjugated SOD at 400 Units/mL
for 1 h prior to addition of dihydroethidium or DCFDA and
exposure to hyperoxia (3 h).
RNA isolation and real time RT-PCR
Total RNA was isolated from HPAECs grown on 35-mm
dishes using TRIzol® reagent (Invitrogen, Carlsbad, CA), ac-
cording to the manufacturer’s instruction. iQ SYBR Green Su-
permix was used to do the real time using iCycler by Biorad
(Hercules, CA). 18S rRNA (sense, 5-GTAACCCGTTGAACC-
CCATT-3, and antisense, 5-CCATCCAATCGGTAGTAGCG-
3) was used as a housekeeping gene to normalize expression.
The reaction mixture consisted of 0.3 g of total RNA (target
gene) or 0.03 g of total RNA (18 S rRNA), 12.5 l of iQ SYBR
Green, 2 l of cDNA, 1.5 M target primers, or 1 M 18 S
rRNA primers, in a total volume of 25 l. For all samples, re-
verse transcription was carried out at 25°C for 5 min, followed
by cycling to 42°C for 30 min, and 85°C for 5 min with iScript
cDNA synthesis kit. Amplicon expression in each sample was
normalized to its 18 S rRNA content. The relative abundance
of target mRNA in each sample was calculated as 2 raised to
the negative of its threshold cycle value times 106 after being
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normalized to the abundance of its corresponding 18 S
rRNA,(2(primer Threshold Cycle)/2(18 S Threshold Cycle)  106). All
primers were designed by inspection of the genes of interest
and were designed using Beacon Designer 2.1 software (Palo
Alto, CA). Negative controls, consisting of reaction mixtures
containing all components except target RNA, were included
with each of the RT-PCR runs. To verify that amplified prod-
ucts were derived from mRNA and did not represent genomic
DNA contamination, representative PCR mixtures for each
gene were run in the absence of the RT enzyme after first be-
ing cycled to 95°C for 15 min. In the absence of reverse tran-
scription, no PCR products were observed.
Preparation of nuclear extracts
Nuclear extracts were prepared from HPAECs according
to the manufacturer’s instructions (Active Motif North
America, Carlsbad, CA). Briefly, cells were collected by
scraping in ice-cold PBS with phosphatase inhibitors and pel-
leted by centrifuging at 1,000 g for 5 min. The pellet was re-
suspended in 500 l of 1X hypotonic buffer and incubated
on ice for 15 min, followed by addition of 25 l of detergent
and high speed vortexing for 30 s, following the manufac-
turer’s recommendation. The suspension was centrifuged at
14,000 g for 20 min in a microcentrifuge at 4°C; the nuclear
pellet was resuspended in 50 l of lysis buffer A and incu-
bated on ice for 15 min. This suspension was centrifuged for
10 min at 14,000 g in a microcentrifuge, and the supernatant
(nuclear extract) was aliquoted and stored at 80°C for fur-
ther analysis. Protein in the nuclear extract was quantified
by BCA protein assay.
Determination of hyperoxia-induced production of O2,
and total ROS
Two methods were used to measure total ROS or O2 by
spectrofluorimetry or fluorescence microscopy. Hyperoxia-
induced O2 release by HPAECs was measured by hy-
droethidine fluorescence as described (7, 27). Total ROS pro-
duction in HPAECs exposed to either normoxia or hyperoxia
was determined by the DCFDA fluorescence method (16).
Briefly, HPAECs (90% confluent in 35-mm dishes) were
loaded with 10 M DCFDA in EGM-2 basal medium and in-
cubated at 37°C for 30 min. Fluorescence of oxidized DCFDA
in cell lysates, an index of formation of ROS, was measured
with an Aminco Bowman series 2 spectrofluorimeter
(Waltham, MA) using excitation and emission set at 490 and
530 nm, respectively, with appropriate blanks. Hyperoxia-
induced ROS formation in cells was also quantified by fluo-
rescence microscopy. HPAECs (90% confluent) in 35-mm
dishes were loaded with DCFDA (10 M) in EBM-2 basal
medium for 30 min at 37°C in a 95% air, 5% CO2 environ-
ment. After 30 min of loading, the medium containing
DCFDA was aspirated; cells were rinsed once with EGM-2
complete medium; cells were preincubated with agents for
the indicated time periods, followed by exposure to either
normoxia (95% air, 5% CO2) or hyperoxia (95% O2, 5%CO2)
for 3–72 h. At the end of the incubation, cells were washed
twice with PBS at room temperature and were examined un-
der a Nikon Eclipse TE 2000-S fluorescence microscope with
Hamamatsu digital CCD camera (Bridgewater, NJ) using a
20X objective lens and MetaVue software (Universal Imag-
ing Corp., PA). For measuring superoxide O2 in the nu-
cleus of HPAECs, DHE (dihydroethidium, Invitrogen, Inc.)
was loaded 30 min prior to hyperoxia exposure of cells for
3h. Images were taken with Nikon Eclipse Microscope at 60X.
Determination of H2O2 by Amplex Red assay
H2O2 formation in the medium or nuclear fraction was de-
termined by fluorescence method using an Amplex Red Hy-
drogen Peroxide Assay kit (Molecular Probes). HPAECs
were transfected with scrambled or Nox4 siRNA for 48 h,
further, nuclear fractions were isolated with Nuclei EZ Prep
Nuclei Isolation Kit (Sigma). These prepared nuclear frac-
tions were exposed to normoxia (95% air–5% CO2) or hy-
peroxia (95% O2–5% CO2) for 3 h in 1.0 ml of phenol red-
free medium (GIBCO-BRL medium 199). At the end of
incubation, the medium was collected and centrifuged at
4,000 g for 5 min, and fluorescence of the medium was mea-
sured on an Aminco Bowman series 2 spectrofluorimeter
with excitation and emission set at 560 and 590 nm, respec-
tively, using appropriate blanks and expressed as percent-
age of normoxic controls.
Immunofluorescence microscopy
HPAECs grown on coverslips to 95% confluence in EGM-
2 complete medium as indicated, followed by exposure to ei-
ther normoxia or hyperoxia for 3 h. Coverslips were rinsed with
phosphate-buffered saline and treated with 3.7% formaldehyde
in phosphate-buffered saline at room temperature for 20 min.
After washing with phosphate-buffered saline, coverslips were
incubated in blocking buffer [1% bovine serum albumin in tris-
buffered saline tween-20 (TBST)] for 1 h. Cells were subjected
to immunostaining with total Nox4 antibody or Nox2 antibody
or p22phox antibody (1: 200 dilution) for 1 h and washed three
times with TBST, followed by staining with Alexa Fluor 488
(1:200 dilution in blocking buffer) for 1 h. After washing at least
three times with TBST, the coverslips were mounted using
commercial mounting medium (Kirkegaard and Perry labora-
tories, Gaithersburg, MD) and were examined by immunoflu-
orescence microscopy with Hamamatsu digital camera using
a 60X oil immersion objective and MetaVue software.
Immunohistochemistry
The 4-mm sections from paraffin-embedded tissues were
mounted on poly-L-lysine-coated slides. After pretreatment
of the sections, they were incubated with rabbit polyclonal
anti-Nox2 or anti-Nox4 antibody diluted at 1:200 in a moist
chamber overnight at 4°C. After washing in 0.01 M PBS, the
sections were incubated for 30 min at room temperature with
biotinylated goat anti-rabbit immunoglobulin antibody.
Then, peroxidase-conjugated streptavidin (Vector Laborato-
ries, Burlingame, CA) was applied. After washing out the ex-
cess complex, the localization of immunoreactive complexes
was visualized after incubation of the sections for 5–10 min
in 50 mM Tris–HCl (pH 7.6) containing 0.02% (wt/vol) 3,39-
diaminobenzidine tetrahydrochloride and 0.03% (wt/vol)
H2O2. Normal rabbit pre-immune serum was applied onto
slides in each staining as a control.
Preparation of cell lysates and Western blot analysis
HPAECs grown on 100-mm dishes (90% confluence)
were rinsed twice with ice-cold phosphate-buffered saline
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and lysed in 100 l of modified lysis buffer (50 mM Tris-
HCl, pH 7.4, 150 mM NaCl, 0.25% sodium deoxycholate, 1
mM EDTA, 1 mM phenylmethylsulfonyl fluoride, 1 mM
Na3VO4, 1 mM NaF, 10 g/ml aprotinin, 10 g/ml leu-
peptin, and 1 g/ml pepstatin), sonicated on ice with a probe
sonicator (three times for 15 s), centrifuged at 5,000 g in a
microcentrifuge (4°C for 5 min), and protein concentrations
of the supernatants were determined using a Pierce protein
assay kit. The supernatants, adjusted to 1 mg of protein/ml
(cell lysates) were denatured by boiling in SDS sample buffer
for 5 min, and samples were separated on 10% SDS-poly-
acrylamide gels and analyzed by Western blotting. Nox4 an-
tibody was used at 1:1,000 dilution while Nox2 and p22phox
antibodies were used at 1:2,000 dilutions. Protein bands were
transferred overnight (24 V, 4°C) onto nitrocellulose mem-
brane (BioRad, 0.45 m), probed with primary and sec-
ondary antibodies according to the manufacturer’s protocol,
and immunodetected by using the ECL kit (Amersham Bio-
sciences). The blots were scanned (UMAX Power Lock II,
Dallas, TX) and quantified by an automated digitizing sys-
tem UN-SCAN-IT GEL (Silk Scientific Corp, Orem, CT).
Endothelial cell migration
HPAECs (control and transfected by siRNA) cultured in
12- or 6-well plates to 95% confluence were starved in 1%
FBS EBM-2 medium for 3 h. The cell monolayer was
wounded by scratching across the monolayer with a 10 l
standard sterile pipette tip. The scratched monolayer was
rinsed twice with serum-free medium to remove cell debris
and incubated for 16 h in 1% FBS EBM-2 under normoxia or
hyperoxia. The area (1 cm2 total) in a scratched area was
recorded at 0 and 16 h using a Hamamatsu digital camera
connected to the Nikon Eclipse TE2000-S microscope with
10X objective and MetaVue software (Universal Imaging
Corp., Sunnyvale, CA) and images were analyzed by the Im-
age J software. The effect of hyperoxia on cell migration/
wound healing was quantified by calculating the percentage
of the free area not occupied by cells compared to an area of
the initial wound that was defined as closure of wounded
area.
Capillary tube formation (in vitro angiogenesis assay)
HPAECs, after silencing with Nox4 or Nox2 siRNA, were
plated on growth factor-reduced Matrigel (basement mem-
brane extract, Trevigen, Inc, Gaithersburg, MD), exposed to
either normoxia or hyperoxia (95% O2), and grown for 5
days. Endothelial growth medium was replaced every day
and capillary tube formation and completion of ring like
structures were recorded.
Transfection of siRNA for Nox4, Nox2, and p22phox
To optimize conditions for efficient transfection, HPAECs
were transfected with Fl-Luciferase GL2 Duplex siRNA (tar-
get sequence, 5-CGTACGCGGAATACTTCGA-3; Dharma-
con) as a positive control. HPAECs, grown to 60% conflu-
ence in 35-mm dishes, were transfected with Gene Silencer®
(Gene Therapy System, Inc., San Diego, CA) transfecting
agent plus with siRNA (50 nM) in serum-free EBM-2
medium according to the manufacturer’s recommendation.
After 3 h post-transfection, 1 ml of fresh complete EGM-2
medium containing 10% FBS was added, and cells were cul-
tured for an additional 24–72 h for analysis of mRNA by real-
time PCR and protein expression by Western blot analysis.
Transfection of Nox4 wild-type plasmid
For transient transfection, HPAECs grown in 6-well
plates ( 60% confluence), were transfected with Nox4 wt
plasmid (1 g of cDNA was mixed with 6 l of Fugene
6/well in 1 ml of EGM), according to manufacturer’s rec-
ommendations. After 3 h, the transfection medium was as-
pirated and 2 ml of complete EGM was added; cells were
allowed to grow prior to exposure to either normoxia or
hyperoxia for 48 h.
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TABLE 1. RELATIVE MRNA EXPRESSIONS OF NADPH OXIDASE COMPONENTS AND PRIMER SEQUENCES
NADPH oxidase
component HPAEC HLMVEC Human gene Primer sequence 5 to 3
Nox1 0.079 0.061 Nox 1: TTCACCAATTCCCAGGATTGAAGTGGATGGTC
Nox2 0.028 0.039 2: GACCTGTCACGATGTCAGTGGCCTTGTCAA
Nox3 0.194 0.313 gp91phox 1: GTCACACCCTTCGCATCCATTCTCAAGTCAGT
Nox4 35.06 22.98 2: CTGAGACTCATCCCAGCCAGTGAGGTAG
p22phox 92.51 112.26 Nox3 1: ATGAACACCTCTGGGGTCAGCTGA
p40phox 0.003 0.086 2: GGATCGGAGTCACTCCCTTCGCTG
p47phox 0.1369 0.212 Nox4 1: CTCGAGGAGCTGGCTCGCCAACGAAG













Male Nox2/(gp91phox/) mice (background C57BL/6) and
C57BL/6J mice were obtained from Jackson Laboratories, Bar
Harbor, Maine. At 8 weeks of age, animals were exposed to
either normoxia or hyperoxia for 24–72 h in a Plexiglass cham-
ber designed for animal procedures. The chamber was sup-
plied with 95% oxygen; oxygen saturation inside the chamber
was monitored by an oxygen sensor (Pro ox 110, BioSpherix
Inc, Redfield, NY). Mice were supplied with fresh water and
Harlan Teklad diet. Animals which were weak and show
symptoms of loss of weight were excluded from the study. Ex-
periments conformed to the Guide for the Care and Use of Labo-
ratory Animals published by the US National Institutes of
Health (NIH publication No. 85-23) and were approved by the
Institutional Animal Care and Use Committee of The Univer-
sity of Chicago. Bronchoalveolar lavage (BAL) was performed
on mice with HBSS via a polyurethane catheter placed in the
trachea. BAL fluid was collected on ice; cells from the lavage
were analyzed by cytological techniques. At the end of the ex-
periment, mice were anesthetized and lungs were perfused
with fresh PBS several times; whole lungs without trachea were
stored in liquid nitrogen. These samples were further
processed for paraffin embedment, sectioning, and staining for
Nox4 and Nox2 by the histological core facility at the Univer-
sity of Chicago. Tissue samples were processed for RNA us-
ing a polytron homogenizer (Brinkmann Gmbh, Westbury,
NY) with Trizol (Invitrogen). For assessment of lung capillary
leakage, Evans blue dye (EB) (20 mg/kg) was injected into the
internal jugular vein 30 min before the termination of the ex-
periment to assess vascular leak. The lungs were perfused free
of blood (perfusion pressure, 5 mm Hg) with phosphate-
buffered saline (PBS) containing 5 mM ethylenediaminete-
traacetic acid, via thoracotomy, excised en bloc, blotted dry,
weighed, and snap-frozen in liquid nitrogen. The right lung
was homogenized in PBS (1 ml/100 g tissue), incubated with
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FIG. 1. Effect of hyperoxia on mRNA ex-
pression of Nox and phox family NADPH
oxidases in HPAECs. HPAECs grown to
90% confluence were exposed to nor-
moxia (room air) or hyperoxia (95% O2) for
12, 24, 48, and 72 h. Total RNA was ex-
tracted and expressions of Nox and phox
homologues were quantified by real-time
RT-PCR and normalized with 18S rRNA.
The values are mean  S.E.M for three in-
dependent experiments. *significantly dif-
ferent from normoxia (p  0.05); **signifi-
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2 volumes of formamide (18 h, 60°C), and centrifuged at 5,000
g for 30 min. The optical density of the supernatant was de-
termined spectrophotometrically at 620 nm. The extravasated
EB concentration in lung homogenate was calculated against
a standard curve (micrograms Evans blue dye per lung).
Statistical analyses
Analysis of variance and Student–Newman–Keul’s test
were used to compare means of two or more different treat-
ment groups. The level of significance was set to p  0.05 un-
less otherwise stated. Results are expressed as mean 
S.E.M.
Results
Expression of Nox and phox family NADPH oxidase
components in HPAECs under normoxia and hyperoxia
At least twelve components of nonphagocytic and
phagocytic NADPH oxidases have been identified in
Genebank. To study the expression of these homologues
in human vascular endothelium by real-time RT-PCR, spe-
cific primers were designed (Table 1). Analyses of the to-
tal RNA by real time RT-PCR, normalized to 18S rRNA,
show that HPAECs and HLMVECs express most of the
NADPH oxidase components, namely, Nox2 (gp91phox),
p47phox, p67phox, p40phox, and p22phox, and the recently de-
scribed Nox1, Nox3, and Nox4 homologues (Table 1).
However, expression of Nox5 was not detected by real-
time RT-PCR, under similar gene amplification cycles.
Among the Nox family NADPH oxidases, expression of
Nox4 was significantly higher (1,000 fold) compared to
Nox1, Nox2, and Nox3. In both HPAECS and HLMVECs,
the expression of p22phox was 3- to 5-fold higher compared
to Nox4, whereas the expression of p40phox, p47phox , and
p67phox were lower (Table 1).
Since hyperoxia stimulates activation of NADPH oxi-
dase and ROS/O2 production in vascular endothelium
(4), and causes lung injury (26), we investigated the effect
of exposure of hyperoxia (95% oxygen) on the mRNA ex-
pression of Nox and phox components of NADPH oxidase.
As shown in Fig. 1, exposure of HPAECs to hyperoxia for
12–72 h increased the mRNA expressions of Nox4 and
p22phox, as determined by real-time RT-PCR normalized to
18S rRNA. However, changes in the expression of Nox1,
Nox2, p40phox, and p47phox, in response to hyperoxia, were
much lower compared to Nox4 and p22phox (Fig. 1). The
mRNA profiles of Nox4, Nox2, and p22phox, under nor-
moxia and hyperoxia, were validated by Western blot anal-
ysis, which showed increased protein expressions of Nox4
(65kDa) at 3 and 24 h of hyperoxia (Fig. 2A), while Nox2
protein expression was enhanced only at 24 h of exposure
to hyperoxia (Fig. 2B). Further, hyperoxia (3 or 24 h) en-
hanced the mRNA levels of p22phox several fold as com-
pared to normoxic cells; however, change in the protein
















































































FIG. 2. Hyperoxia increases protein expression of Nox4
and Nox2 in HPAECs. HPAECs (90% confluence) were
subjected to normoxia or hyperoxia for 3 or 24 h. Cells were
rinsed twice in ice-cold PBS , total cell lysates (20 g of pro-
tein) were subjected to SDS-PAGE, as described in “Materi-
als and Methods” and analyzed by Western blot analysis
with anti-Nox4 (Santa Cruz, CA), -Nox2 (gp91phox), and 
-p22phox antibodies. Shown are representative Western blots
from three independent experiments. Blots were scanned
and quantified by automated digitized system UN-SCAN-
IT-GEL. *significantly different from cells exposed to nor-
moxia (p  0.05).
Effect of hyperoxia on localization of Nox4 and 
p22phox in HPAECs
There are reports on the localization of Nox4 either in en-
doplasmic reticulum or nucleus of mammalian cells (20, 41).
Therefore, immunofluorescence studies were carried out to
determine the localization of Nox4 and p22phox in HPAECs
under conditions of normoxia and hyperoxia. As shown in
Fig. 3A, Nox4 was primarily localized in cell nucleus under
normoxia, and exposure of cells to hyperoxia (3 or 24 h) re-
sulted in redistribution of Nox4 to the cytoplasm and plasma
membrane as determined by confocal microscopy. In con-
trast to Nox4, p22phox was localized to structures resembling
endoplasmic reticulum in normoxia and in punctate nuclear
structures after exposure to hyperoxia (Fig. 3A). Addition-
ally, merging of the immunofluorescence stains of Nox4
(green) and p22phox (red) showed colocalization (yellow) in
the nucleus under hyperoxia (Fig. 3A). The nuclear im-
munolocalization of Nox4 and p22phox was confirmed by iso-
lation of enriched nuclear fraction and Western blot analy-
sis for Nox4 and p22phox. As shown in Fig. 3B, Western blot
analysis of the cytoplasm and isolated nuclear fractions re-
vealed higher levels of Nox4 in the nucleus compared to the
cytoplasm fraction. Further, nuclear fraction also showed
staining for p22phox by Western blotting. The purity of the
isolated nuclear preparation was verified by expression of
lamin B1 (nuclear cytoskeletal protein), absence of lactate de-
hydrogenase (cytoplasmic enzyme), and calreticulin (marker
of endoplasmic reticulum). Further, exposure of HPAECs to
hyperoxia for 3 or 24 h increased the protein expression of
Nox4 in the nuclear and cytoplasmic fractions (Fig. 3B); how-
ever, no such increase in the expression of p22phox in the nu-
clear fraction was observed after 3 h hyperoxia. Interestingly,
the expression of p22phox was also enhanced at 24 h of hy-
peroxia (Fig. 3B). Under similar exposure to hyperoxia (3 or
24 h), nuclear localization of Nox2 and p47phox was not de-
tected (data not shown). To further confirm the nuclear lo-
calization of Nox4, expression of Nox4 was downregulated
by transfection of HPAECs with Nox4 siRNA (50 nM) for 48
h, which reduced the mRNA and protein expression of Nox4
(	90%) as determined by real-time RT-PCR and Western blot
analysis (Fig. 4A). Analyses of Nox4 siRNA transfected
HPAECs by immunofluorescence microscopy and Western
blot analysis of nuclear fraction also revealed a decrease in
Nox4 expression compared to cells transfected with scram-
bled siRNA (Fig. 4B and C). These results show a nuclear
colocalization of Nox4 and p22phox during hyperoxia in
HPAECs.
Role of Nox4 in hyperoxia-induced ROS generation
Our earlier results show that hyperoxia-induced
ROS/O2 production was dependent upon activation of
NADPH oxidase, rather than mitochondrial electron trans-
port (27), and Nox2 siRNA partly blocked hyperoxia-in-
duced ROS generation in HPAECs (37). To study the func-
tional role of Nox4 in hyperoxia-induced ROS/O2, Nox4
expression was downregulated with Nox4 siRNA or upreg-
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FIG. 3. Localization of Nox4 and p22phox under normoxia and hyperoxia in HPAECs. (A) HPAECs grown on glass cov-
erslips were exposed to normoxia (N) or hyperoxia (HO) for 3 h, washed, fixed, permeabilized and probed with anti-Nox4
(from Dr. Lambeth) or anti-p22phox antibodies. Hyperoxia induced association of Nox4 with p22phox protein (yellow in merged
image) shown is a representative confocal immunofluorescence image from three independent experiments. (B) HPAECs in
100-mm dishes grown to 90% confluence were exposed to normoxia or hyperoxia for 3 or 24 h. Nuclear and cytoplasmic
fractions were prepared using Active Motif according to manufacturer’s protocol as described in “Materials and Methods.”
Lysates from nuclear and cytoplasmic fractions (20 g protein) were subjected to SDS-PAGE and Western blot analysis with
antibodies against Nox4 (Santa Cruz, CA), p22phox, Lamin B1, lactate dehydrogenase (LDH), and calreticulin. Representa-
tive blots from three independent experiments are shown. (For interpretation of the references to color in this figure leg-
end, the reader is referred to the web version of this article at www.liebertonline.com/ars).
ulated with Nox4 wild-type plasmid. Nox4 downregulation
decreased hyperoxia-induced oxidation of DCFDA fluores-
cence (ROS production), and hydroethidine fluorescence
(O2 generation) by 30% compared to scrambled siRNA
transfected cells exposed to hyperoxia (Fig. 5A and B). In-
terestingly, Nox4 siRNA slightly blocked DCFDA oxida-
tion/hydroethidine fluorescence under normoxia (Fig. 5A
and B). Furthermore, the siRNA for Nox4 was specific as it
did not affect expression of Nox1/Nox3 in HPAECs (results
not shown). Overexpression of Nox4 wild-type plasmid in-
creased oxidation of DCFDA fluorescence (ROS production)
by 1.8 fold compared to vector control cells under nor-
moxia and Nox4 wild-type overexpression further enhanced
hyperoxia-induced DCFDA oxidation (Fig. 5C). Further, pre-
treatment of cells with PEG-SOD almost completely blocked
hyperoxia-induced ROS/O2._ production (Fig. 5A and B)
Taken together, these results suggest a role for Nox4 in hy-
peroxia-induced ROS/O2.- generation in HPAECs.
Hyperoxia-induced ROS production by nuclear Nox4
As Nox4 is predominantly localized in nucleus of
HPAECs, next we investigated the role of nuclear Nox4 in
ROS/O2 production by monitoring generation of H2O2
production/hydroethidine fluorescence under basal and hy-
peroxic conditions. Nuclei isolated from scrambled or Nox4
siRNA transfected cells were exposed to normoxia or hy-
peroxia (3 h). As shown in Fig. 6A, exposure of nuclei from
scrambled siRNA transfected cells to hyperoxia (3 h) accu-
mulated H2O2 (2-fold) compared to normoxic nuclei while
Nox4 siRNA transfected nuclei exhibited reduced H2O2 pro-
duction. Interestingly, downregulation of Nox4 expression
by siRNA reduced basal ROS production under normoxia
(Fig. 6A). Further, cells incubated with hydroethidine showed
a pronounced increase in nuclear hydroethidine fluorescence,
compared to normoxic cells, at 3 h after hyperoxia exposure,
and downregulation of Nox4 with Nox4 siRNA, but not
scrambled siRNA, reduced basal and hyperoxia-induced hy-
droethidine oxidation in the nucleus (Fig. 6B). Quantitation
of the images showed 2.5-fold increase over baseline in nu-
clear hydroethidine fluorescence in hyperoxia and downreg-
ulation of Nox4 reduced hyperoxia-induced nuclear hy-
droethidine fluorescence to 1.5-fold change (Fig. 6C).
Similarly, Nox4 siRNA reduced cytoplasmic hydroethidine
fluorescence (1.3-fold) versus Nox4 siRNA transfected cells
(0.2-fold) at 3 h after hyperoxia (data not shown). These re-
sults suggest a potential role for nuclear Nox4 in generating
ROS/O2 due to hyperoxia in HPAECs.
Knockdown of Nox2 and Nox4 by siRNA upregulates
expression of Nox4 and Nox2, respectively, in HPAECs
Although Nox4 siRNA did not alter the expression of
Nox1 and Nox3 levels, expression of Nox2 mRNA was up-
regulated on silencing Nox4 while Nox4 mRNA and protein
expression were enhanced after knockdown of Nox2 (Fig. 7A
and B). Numerous attempts of simultaneous transfection of
Nox2 and Nox4 in HPAECs resulted in increased cell death
within 48 h (results not shown). Interestingly, siRNA-medi-
ated knockdown of p22phox increased Nox4 mRNA levels by
2-fold (Fig. 7C). A similar compensatory mechanism be-
tween Nox4 and Nox2 after siRNA treatment was observed
in human cardiac ECs; however, in primary human bronchial
epithelial cells and in adenocarcinoma cell line A549, knock-
down of Nox2 and Nox4 by siRNA did not upregulate the
expression of Nox4 or Nox2, respectively (data not shown).
These results show for the first time the ability of lung ECs
to reciprocally compensate for Nox2 or Nox4 deficiency.
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FIG. 4. Nox4 siRNA attenuates hyperoxia induced ex-
pression of Nox4 in nucleus. HPAECs grown on 35-mm
dishes (A and C) or glass coverslips (B) to 50% confluence
were transfected with scrambled siRNA (Sc) or Nox4 siRNA
(50 nM) for 48 h. (A) Total RNA was extracted and Nox4
mRNA expression was quantified and normalized to 18S
rRNA by real-time RT-PCR. Values are average of three in-
dependent determinations. (B) Sc or Nox4 siRNA trans-
fected cells were exposed to normoxia or hyperoxia (3 h),
washed, fixed, permeabilized, and probed with anti-Nox4
antibody (from Dr. Lambeth) or DAPI for nuclear staining
and examined by immunofluorescence microscopy using a
60X oil objective. The Nox4 (red) and DAPI (blue) images
show matched cell fields for each condition. A representa-
tive image from several independent experiments is shown.
(C) Isolated nuclear or cytoplasmic fraction (20 g protein)
were subjected to SDS-PAGE and probed with anti-Nox4
(Santa Cruz, CA), or anti- actin or -lamin B1 antibodies.
Representative blots from three independent experiments
are shown. (For interpretation of the references to color in
this figure legend, the reader is referred to the web version
of this article at www.liebertonline.com/ars).
Effect of hyperoxia on lung injury and expression of Nox4
in control and Nox2 (gp91phox) / mice
Male C57BL/6J or Nox2/ mice with similar genetic
background were exposed to normoxic air or 95% oxygen
(hyperoxia) for 72 h, and at various times, mice from both
groups were evaluated for alveolar-capillary membrane dys-
function by determining protein levels in bronchoalveolar
lavage (BAL) and Evans Blue (EB) dye extravasation. As
shown in Fig. 8A, BAL fluid from mice exposed to hyper-
oxia for 48 and 72 h had significantly higher protein levels
compared to normoxic animals. BAL from hyperoxia-ex-
posed control mice exhibited higher cell counts with in-
creased percentage of macrophages (Fig. 8C). Further,
histopathology of lung sections revealed pulmonary injury
induced by hyperoxia, as evidenced by increased numbers
of fibroblasts and fibrosis (Fig. 8D). Since hyperoxia causes
vascular leak in C57BL/6J mice, next we investigated a role
for NADPH oxidase in hyperoxic lung injury using geneti-
cally altered Nox2/ null mice. Under normoxic conditions,
mice in both the groups showed similar BAL protein levels,
however, in hyperoxia the control mice exhibited increased
alveolar and vascular leakiness (Fig. 8A and B), and influx
of neutrophils into alveolar space compared to the mice with












































































































































FIG. 5. Role of Nox4 in hyperoxia-induced ROS genera-
tion. (A and B) HPAECs grown to 50% confluence in 35-
mm dishes were transfected with scrambled siRNA or Nox4
siRNA (50 nM) for 48 h as described in “Materials and Meth-
ods.” After 48 h, cells were pretreated with medium alone
or medium containing PEG-conjugated SOD at 400
Units/mL for 1 h prior to addition of 10 M DCFDA (A) or
hydroethidine (B) for 30 min and washed once in basal
medium. Cells in A or B were exposed to normoxia or hy-
peroxia (3 h) and at the end of the exposure, formation of
total ROS (A) or superoxide (B) was measured by spectro-
fluorimetry. Values are mean  S.E.M from three indepen-
dent experiments done in triplicate and normalized to total
protein. *significantly different from normoxia (p  0.05);
**significantly different from scrambled siRNA transfected
cells exposed to hyperoxia (p  0.01). (C) HPAECs grown to
70% confluence on 35-mm dishes were transfected with 1
g of plasmid DNA/ml of Nox4 wild type. 72 h later, cells
were loaded with 10 M DCFDA for 30 min, washed once
in basal medium and exposed to normoxia or hyperoxia (3
h). Total ROS production was visualized under immuno-
fluorescence microscopy and quantified as described in
“Materials and Methods.” Values are mean  S.E.M of three
independent experiments. *significantly different from nor-
moxia (p  0.05); **significantly different from vector con-
trol transfected cells under normoxia (p  0.01).
targeted disruption of Nox2 (Fig. 8C), suggesting a role for
Nox2 in hyperoxia-mediated vascular leakiness. Interest-
ingly, exposure of Nox2/ mice to hyperoxia still caused
significant vascular leak as measured by increased BAL fluid
protein, infiltration of macrophages in BAL fluid, and Evans
Blue dye extravasation (Fig. 8A, B, and C), suggesting po-
tential involvement of other Nox family homologues, such
as Nox4, in mediating lung injury.
Having demonstrated that silencing Nox4 and Nox2 up-
regulates the expression of Nox2 and Nox4, respectively,
we next investigated the expression of Nox4 in Nox2/
mice and the effect of hyperoxia on Nox4 expression in the
lungs of control and Nox2/ mice. Analyses of total lung
tissue mRNA by real-time RT-PCR confirmed low expres-
sion of Nox2, compared to Nox4 in control mice (Fig. 9A),
and exposure of control mice to hyperoxia for 48 h in-
creased the expression of Nox2 (relative mRNA expres-
sion, normalized to 18S rRNA, from 0.02 to 0.04), and Nox4
(relative mRNA expression, normalized to 18S rRNA, from
75 to 300) (Fig. 9A). In Nox2/ mice, as expected, there
was no expression of Nox2 mRNA; however, the expres-
sion of Nox4 mRNA was higher compared to control mice
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FIG. 6. Role of ]Nuclear Nox4 in hyperoxia-induced ROS
generation. (A) HPAECs grown to 50% confluence in 100-
mm dishes were transfected with scrambled siRNA or Nox4
siRNA (50nM) or p22phox siRNA (50 nM) for 48 h. Nuclear
fractions were prepared as described in “Materials and
Methods” and exposed to normoxia or hyperoxia for 3 h.
Accumulation of H2O2 was measured using an Amplex Red
assay. Values are mean  S.E.M from three independent ex-
periments and expressed in % control. *significantly differ-
ent from scrambled siRNA normoxic nuclear fraction (p 
0.05), **, significantly different from scrambled siRNA nor-
moxic nuclear fraction (p  0.01). (B and C) HPAECs grown
to 50% confluence in glass-bottom dishes were transfected
with scrambled siRNA or Nox4 siRNA (50 nM) for 48 h. Cells
were loaded with10 M hydroethidine for 30 min and
washed once with basal medium, and further exposed to
normoxia or hyperoxia for 3 h. Formation of superoxide and
enhanced intercalation of oxidized hydroethidine with nu-
clear DNA was visualized under fluorescence microscopy
and quantified. Values are mean  S.E.M from three inde-
pendent experiments in triplicates and expressed as % con-
trol. *significantly different from scrambled siRNA trans-
fected cells under normoxia (p  0.05), **significantly
different from scrambled siRNA transfected cells under nor-
moxia (p  0.01). (For interpretation of the references to color
in this figure legend, the reader is referred to the web ver-
sion of this article at www.liebertonline.com/ars).
under normoxia (control mice, Nox4 expression 75 vs.
Nox2/ mice, Nox4 expression, 225 all normalized to 18S
rRNA) (Fig. 9B). Further exposure of Nox2/ mice to hy-
peroxia did not upregulate the expression of Nox4, in con-
trast to the control mice (Fig. 9B). These results from in vivo
experiments show upregulation of Nox4 expression in
Nox2/ mice and exposure of Nox2/ mice to hyper-
oxia did not further enhance the expression of Nox4, as
compared to control mice. Histological evaluation of sec-
tions of lung from both wild-type mice and Nox2/ (Fig.
9C) show the increased Nox2 and Nox4 expression with
hyperoxia (24 h) (brown staining, DAB, see Materials and
Methods). However, expression of Nox4 in Nox2/ mice
was higher compared to wild-type mice under normoxia,
and exposure to hyperoxia did not further increase Nox4
expression (Fig. 9C).
Nox2 and Nox4 mediate hyperoxia-induced migration and
capillary tube formation in HPAECs
Having established a role for Nox4 in hyperoxia-induced
ROS/O2 generation in HPAECs, we next determined the
functional significance of the ROS production in cell migra-
tion and capillary tube formation. Exposure of HPAECs to
hyperoxia (16 h) increased migration (Fig. 10A), which was
blocked by N-acetylcysteine (NAC) (Fig. 10A, lower panel).
Further, NAC attenuated hyperoxia-induced ROS genera-
tion in HPAECs (Fig. 10B). Next, we investigated the role of
Nox4 and Nox2 in EC motility and capillary tube formation.
In these experiments, 35-mm dishes were seeded with the
same number of cells (5  104) and at 50–60% confluence,
cells were transfected with scrambled siRNA or Nox4 or
Nox2 siRNA. At the end of 48 h, both the scrambled and
siRNA transfected cells reached similar confluence, indicat-
ing that downregulation of Nox4 or Nox2 did not affect cell
growth/proliferation in HPAECs (data not shown). How-
ever, transfection of HPAECs with Nox4 or Nox2 siRNA at-
tenuated hyperoxia-induced migration and capillary tube
formation, compared to control cells transfected with scram-
bled siRNA (Figs. 11 and 12). These results support a role
for Nox4- and Nox2-dependent generation of ROS in hy-
peroxia-induced migration and capillary tube formation in
lung ECs.
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FIG. 7. Silencing of Nox2 and Nox4 by siRNA upregu-
lates expression of Nox4 and Nox2, respectively. HPAECs
grown on 35-mm dishes to 50% confluence were trans-
fected with 50 nM scrambled siRNA or Nox2 siRNA or Nox4
siRNA or p22phox siRNA for 48 h. (A and B) Total RNA was
isolated and mRNA levels of Nox2 and Nox4 were quanti-
fied by real-time RT-PCR and normalized to 18S rRNA. In
parallel experiments, total cell lysates (20 g protein) from
scrambled siRNA or Nox2 siRNA or Nox4 siRNA transfected
cells were subjected to SDS-PAGE and Western blotted anti-
Nox4 (Santa Cruz, CA) (A) or anti-Nox2 (B) antibodies. Val-
ues are average of three independent experiments. Shown
are representative of blots from three separate experiments.
(C) Total RNA was isolated and mRNA levels of p22phox were
determined by real-time RT-PCR and values are average of
three independent experiments.
Discussion
The present study supports a role for Nox4 in hyperoxia-
induced ROS/O2 generation in HPAECs. Our results in-
dicate that ROS generated via Nox4 and Nox2 regulates hy-
peroxia-induced EC migration and capillary tube formation.
Our results also show that independent downregulation of
Nox4, and Nox2 with siRNA upregulated the mRNA and
protein expression of Nox2 and Nox4, respectively, in
HPAECs. This novel compensatory mechanism between
Nox4 and Nox2 expression was also evident in Nox2/
mice that exhibit increased levels of basal Nox4 expression
compared to control wild-type mice.
ROS generated by the Nox family of NADPH oxidases
have emerged as an important regulatory and signaling mol-
ecule modulating vascular cell growth, migration, cy-
toskeletal organization, and barrier function (31). Among the
five Nox homologues, namely Nox1, Nox2, Nox3, Nox4, and
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FIG. 8. Effect of hyperoxia
on lung injury in C57BL/6J
and Nox2/ mice. (A)
C57BL/6J mice or Nox2/
mice were exposed to nor-
moxia (room air-21% oxygen)
or hyperoxia (95% oxygen) for
24, 48, and 72 h. Mice were
anesthetized by intraperi-
toneal injection of 30 l of ke-
tamine (100 mg/kg)/xylazine
(10 mg/kg). BAL (bron-
choalveolar lavage) fluid was
aspirated from the lungs and
stored on ice before measur-
ing total protein. Each group
had five mice and values are
mean  S.E.M of three inde-
pendent experiments. (B) The
levels of extravasated Evans
blue dye (g/ml/g body
weight) in mouse lung ho-
mogenate of wild type and
Nox2/ mice are shown.
Values are mean  S.E.M of
three independent experi-
ments. (C) BAL fluids were
centrifuged at 200 g for 10 min,
and the pellet was immedi-
ately resuspended in physio-
logical saline for total cell
counts. Differential cell counts
were carried out in the cen-
trifuged cells after Wright–
Giemsa staining. (D) shows
the histological staining of the
lung tissue from mice exposed
to normoxia or hyperoxia.
Lung tissues were stored in
formalin for 24 h before pro-
cessing to cut and mount the
section for staining with H&E.
Shown is a representative
staining of the lung tissue
from three independent deter-
minations. (For interpretation
of the references to color in
this figure legend, the reader
is referred to the web ver -
sion of this article at www
.lieberton line.com/ars).
Nox5 that have been identified in mammalian cells and tis-
sues (19), Nox2 is predominantly present in neutrophils.
Nox4, first identified in the kidney, is highly expressed in
vascular ECs and smooth muscle cells (32). Our results show
that Nox4 is the most abundant isoform expressed in
HPAECs and HLMVECs, confirming the earlier reports of
higher Nox4 expression in HUVECs and vascular smooth
muscle cells (10). Although Nox4 mRNA expression in
HPAECs and HLMVECs was 1,000 fold higher compared
to Nox2 expression, and Western blot analyses revealed that
both Nox4 and Nox2 exhibit similar levels of protein ex-
pression. Protein expression is dictated by several factors, in-
cluding level of mRNA half life, translation, and turnover
rate of the protein of interest. It is evident that there is no di-
rect correlation between mRNA expression levels and pro-
tein expression, and in many instances, an increase in mRNA
expression does not necessarily translate to similar level of
protein expression (12, 14). In HPAECs, hyperoxia (24 h) in-
creased mRNA levels by 8-fold compared to normoxia;
however, the protein expression was enhanced by 3-fold
after hyperoxia.
In the vasculature, Nox-derived ROS have been implicated
in a variety of cellular responses under normal and patho-
logical conditions. Nox1-derived O2 production by ad-
vanced glycation endproducts activate NF-kB-dependent
iNOS in rat thoracic aorta smooth muscle cells (30), and a re-
cent study suggests a strong link between Nox1-derived ROS
by angiotensin II and a hypertensive signaling element in
vasculature (21). Whereas Nox2-derived ROS by activated
leukocytes have been functionally linked to host defense
against bacterial infections (1), the function of Nox4- and
Nox2-derived ROS in the vasculature appears to be complex
and dependent on the relative expression levels of the Nox
isoforms, and the type(s) of vascular cells involved. Nox2-
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FIG. 9. Effect of hyperoxia on Nox4 mRNA ex-
pression and immunohistochemical staining of
control and Nox2/ mice. (A) Lung tissues were
harvested from wild-type-C57BL/6J mice exposed
to normoxia or hyperoxia (24 h). Total RNA was
isolated, Nox2 and Nox4 mRNA were quantified by
real-time RT-PCR and normalized to 18S rRNA.
*significantly different from normoxic lung tissue
(p  0.05). (B) Nox2/ mice were exposed to ei-
ther normoxia or hyperoxia (95% O2 for 24 h). To-
tal RNA was isolated and mRNA levels of Nox4
were quantified by real-time RT-PCR and normal-
ized to 18S rRNA. (C) Lung tissues from wild-type
and Nox2/ mice were stained with Nox2 and
Nox4 antibodies using standard immunohisto-
chemistry (immuno-peroxidase) techniques. (For
interpretation of the references to color in this fig-
ure legend, the reader is referred to the web ver-
sion of this article at www.liebertonline.com/ars).
derived ROS may alter the interactions between blood cells
and cells of the vessel wall to mediate cerebral microvascu-
lar dysfunction in sickle cell transgenic mice (42). Expression
of Nox4 and other members of the Nox family are modu-
lated in response to vascular injury and agents that induce
damage to the vessel wall. Upregulation of Nox1 in arterial
smooth muscle cells and an increase in Nox2 level in cells of
adventitial origin during restenosis after carotid injury were
observed as an early event that was followed by increased
expression of Nox4 in smooth muscle cells (35). Similarly,
differences in the relative expression of Nox2 and Nox4 in
saphenous veins and arteries from patients undergoing coro-
nary bypass surgery has been reported (13); however, the
relative contributions of Nox4 and Nox2 to ROS production
was not directly addressed. In HPAECs, blocking Nox2 with
Nox2 siRNA blocked 70% of hyperoxia-induced ROS/O2
production as measured by DCFDA/hydroethidine oxida-
tion, respectively (37). Similar to Nox2 siRNA, in the pres-
ent study, knockdown of Nox4 with Nox4 siRNA only par-
tially blocked hyperoxia-induced ROS/O2 accumulation.
Thus, in HPAECs, these combined results demonstrate the
involvement of both Nox4 and Nox2 in hyperoxia-induced
ROS generation. Interestingly, simultaneous knockdown of
Nox2 and Nox4 with siRNA affected cell morphology, and
induced cell death, suggesting a role for basal ROS gener-
ated via Nox2 and Nox4 in maintaining EC morphology and
function. However, it is unclear if apoptosis or necrosis or
both are involved in this process (S. Pendyala and V. Natara-
jan, results not shown).
Although the relative protein expression of both Nox4 and
Nox2 in HPAECs was very similar under normoxia as com-
pared to the mRNA expression (Table 1 and Fig. 2); expo-
sure of cells to hyperoxia for 3 h increased mRNA and pro-
tein expression of Nox4, but not Nox2, which was
concomitant to enhanced ROS generation. However, longer
exposure to hyperoxia (24 h) stimulated Nox2 protein ex-
pression. This differential upregulation of Nox4 and Nox2
by hyperoxia at 3 h suggests that Nox4 could function as an
PENDYALA ET AL760
FIG. 10. N-acetylcysteine attenuates hyperoxia-induced ROS generation and wound healing. HPAECs grown on 35-
mm dishes (A) or glass coverslips to 90% confluence were pretreated with vehicle or vehicle plus N-acetylcysteine (NAC)
1 mM for 60 min. (A) Cells were wounded by scratching across the monolayer with a 10 l sterile pipette tip. The scratched
monolayers were rinsed twice in serum-free medium and exposed to either normoxia (N) or hyperoxia (HO) for 16 h. The
effect of NAC on hyperoxia-mediated cell migration was quantified by calculating the % of free area not occupied by cells
adjacent to an area of the initial wound that was defined as closure of wounded area as described in “Materials and Meth-
ods.” Values are mean  S.E.M of three independent experiments in triplicates. *significantly different from normoxia and
without NAC (p  0.05); **significantly different from cells exposed to hyperoxia without NAC (p  0.01). (B) After NAC
pretreatment for 1 h, cells were loaded with 10 M DCFDA for 30 min, washed once in basal medium, and total ROS for-
mation was quantified using fluorescence microscopy as described in “Materials and Methods.” Values are mean  S.E.M
of three independent experiments and ROS generation expressed as % of control. *significantly different from cells exposed
to normoxia without NAC (p  0.05); **significantly different from cells exposed to hyperoxia without NAC (p  0.01). (For
interpretation of the references to color in this figure legend, the reader is referred to the web version of this article at
www.liebertonline.com/ars).
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FIG. 11. Nox4 and Nox2siRNA attenuates hyperoxia-mediated cell migration. (A and B) HPAECs grown on 35-mm
dishes to 50% confluence were transfected with scrambled siRNA or Nox4 siRNA or Nox2 siRNA for 48 h. Cells were
wounded as described in “Materials and Methods” and Fig. 10, and exposed to either normoxia or hyperoxia for 16 h. Val-
ues are mean  S.E.M of three independent experiments in triplicates. *significantly different from scrambled siRNA trans-
fected cells under normoxia (p  0.05); *significantly different from scrambled siRNA transfected cells under normoxia (p 
0.01); ***significantly different from scrambled siRNA transfected cells under hyperoxia (p  0.001). 
FIG. 12. Nox4 and Nox2 siRNA attenuates hyperoxia-mediated capillary tube formation. (A and B) HPAECs grown in
100-mm dishes to 50% confluence were transfected with scrambled siRNA or Nox4 siRNA or Nox2 siRNA for 48 h. Af-
ter 48 h, cells were trypsinized and seeded onto matrigel-coated 35-mm dishes, as described in “Materials and Methods.”
After 24 h of seeding, cells were either exposed to normoxia or hyperoxia (24 h) and formation of capillary tubes were vi-
sualized under phase-contrast microscope and quantified by counting different areas. Values are mean  S.E.M of three in-
dependent experiments. *significantly different from scrambled siRNA transfected cells under normoxia (p  0.05); **sig-
nificantly different from scrambled siRNA transfected cells under normoxia (p  0.01); ***significantly different from
scrambled siRNA transfected cells under hyperoxia (p  0.00).
oxygen sensor in the human pulmonary endothelium, which
is physiologically at very low oxygen tension, and exposing
them to higher oxygen levels (95%) may trigger induction
of the Nox4 isoform. Recent studies in distal tubular cells of
the kidney also indicate that Nox4 could function as an oxy-
gen sensor (22). Further studies are necessary to clarify the
role of Nox4 as an oxygen sensor in hyperoxia.
Another interesting and novel observation in the present
study was the nuclear localization of Nox4 and p22phox and
redistribution of Nox4 from the nucleus to the cytosol after
exposure of cells to hyperoxia. This was based on the distri-
bution of native Nox4 in isolated nuclear fraction by im-
munofluorescence microscopy and Western blot analysis for
Nox4 as well as the ability of Nox4 siRNA to knockdown
Nox4 expression in nuclei. However, there are conflicting re-
ports on the subcellular localization of Nox4 in nonphago-
cytic cells. In smooth muscle cells, Nox4 colocalizes with vin-
culin in focal adhesions and cell fractionation suggests
nuclear localization of Nox4 (15), while in human aortic
smooth muscle cells, Nox4 was localized in endoplasmic
reticulum (16, 28). In HUVECs, native Nox4 was mainly nu-
clear; however, microinjection of Nox4-GFP fusion protein
largely localized to endoplasmic reticulum (39), suggesting
the possibility that the GFP tag may alter the localization of
Nox4 protein. Thus, there are major differences in the cellu-
lar localization of native Nox4 versus overexpressed Nox4 for
a given cell type. Although native Nox4 seems to have a pre-
dominant nuclear localization (32), the physiological signif-
icance of this nuclear localization of Nox4 is unclear. From
our studies, we show that nuclear Nox4 is involved in the
generation of hyperoxia-induced ROS/O2 (Fig 6A). There
is one report showing that Nox4 activity is independent of
regulatory subunits in cell-free preparations from a tet-in-
ducible system that allowed controlled Nox4 expression (17).
This is consistent with earlier studies which showed that,
while Nox4 requires p22phox, mutation of the p22phox proline-
rich domain (which serves as a docking site for other regu-
latory subunits) did not affect the activity of Nox4 (17). Fur-
ther, a recent study shows that the nuclear fraction from
HUVECs exhibits an NADPH-dependent O2 producing ac-
tivity supporting the role of Nox4 in generating ROS in the
nucleus, where Nox4 likely forms a functional complex with
p22phox (20). During analyses of Nox4, we did not detect any
p47phox or Nox2 in the nuclear fractions; however, presence
of p22phox was detected in the nuclear fraction by Western
blot analysis and immunofluorescence microscopy. Further-
more, immuno-colocalization studies support an association
between Nox4 and p22phox within the nucleus after 24 h ex-
posure of cells to hyperoxia (Fig. 3A).
Accumulating evidence suggests that Nox enzymes are
important sources of ROS in vascular tissues and cells, and
enhanced production has been linked to the pathophysiol-
ogy of several vascular/pulmonary disorders. In this con-
text, our present results are novel, demonstrating existence
of a compensatory mechanism in the endothelium for basal
ROS generation in nanomolar range. We have shown that
knockdown of Nox4 or Nox2 with siRNA upregulates the
mRNA and protein expression of the other Nox homologue
in HPAECs. A similar compensation of Nox4 mRNA was ob-
served in Nox2/ mice. Although Nox2/ mice devel-
oped less lung injury, compared to control mice after expo-
sure to hyperoxia for 48 and 72 h, our results show that dele-
tion of Nox2 gene did not abrogate hyperoxia-induced lung
injury suggesting potential roles of other Nox family mem-
bers, such as Nox4, in ROS generation and lung injury. Si-
lencing Nox4 with Nox4 siRNA increases Nox2 protein ex-
pression after 24 h of hyperoxia in HPAECs; therefore,
conditional deletion of Nox4 or Nox2 or both in the lung will
specifically address the role of these two Nox homologues
in ROS generation in lung under normal and pathophysio-
logical conditions.
The present work also provides evidence for the first time
of Nox4-derived ROS in hyperoxia-induced EC motility and
capillary tube formation. A similar role for Nox2-derived
ROS in EC migration was observed in HPAECs as well as in
HUVECs, suggesting a pivotal role of Nox-derived ROS in
angiogenesis (38). Although, downregulation of Nox2 or
Nox4 with siRNA upregulated protein expression of Nox4
or Nox2, respectively, the total ROS produced under hyper-
oxia was partially reduced compared to normoxia, indicat-
ing that the compensated protein may not be totally func-
tional or may have a different spatial organization. Similarly,
with wound closure or capillary tube formation after expo-
sure to hyperoxia, a complete compensation of the function
with Nox2 or Nox4 siRNA was not observed (Figs. 11 and
12). These results also suggest that the expression of both
Nox4 and Nox2 are critical for optimal ROS production,
wound closure, and tube formation in response to hyperoxia.
Additionally, Nox4 and Nox2 proteins may have signaling
function(s), independent of ROS generation, in cell motility
and angiogenesis, which warrants further investigation. In
human airway smooth muscle cells, Nox4 mediates TGF-1-
induced phosphorylation of retinoblastoma protein, prolif-
eration, and hypertrophy, which are redox-dependent (33).
Although ROS-derived from Nox4 or Nox2 could account
for many of the signaling cascades and functions in vascu-
lar cells, Nox4 may have a role in oxygen sensing in the kid-
ney cortex (11), and to regulate TASK-1 activity (22). Further
more, an increasing number of studies point to Nox-derived
ROS being anti-apoptotic in pancreatic cancer cells (40),
while Nox1 regulates apoptosis and potentially stimulates
branching morphogenesis in sinusoidal endothelial cells (18)
In summary, our study demonstrates a role for Nox4 and
Nox2 in hyperoxia-induced ROS/O2 production in an in
vitro model of human lung ECs and in an in vivo Nox2/
murine model. Our results show that Nox4 mRNA and pro-
tein expression are upregulated by hyperoxia and the in-
volvement of Nox4 as well as Nox2 in hyperoxia-induced
ROS/O2 production in HPAECs. We also demonstrate that
hyperoxia-induced cell migration and capillary tube forma-
tion are regulated by ROS generated via a Nox4-dependent
pathway. In Nox2/ mice, we demonstrate higher basal ex-
pression of Nox4 mRNA compared to control mice, sug-
gesting the induction of a compensatory mechanism for Nox-
dependent ROS generation. While the exact mechanism of
hyperoxia-induced upregulation of Nox4 expression in
HPAECs and mouse lung from Nox2/ mice is yet to be
defined, our studies indicate a potential role for Nrf2 in hy-
peroxia-induced Nox4 expression (29). Further studies are in
progress to unravel the role of Nrf2 and related signaling
pathways activated by hyperoxia in regulating Nox4 ex-
pression and ROS/O2 production in vascular endothelium.
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